Literature DB >> 19648420

Annual screening for prostate cancer did not reduce mortality from prostate cancer.

Steven E Canfield1.   

Abstract

Entities:  

Year:  2009        PMID： 19648420     DOI： 10.1136/ebm.14.4.104

Source DB:  PubMed          Journal:  Evid Based Med        ISSN： 1356-5524


× No keyword cloud information.
  3 in total

1.  Screening for Prostate Cancer: A Review of the ERSPC and PLCO Trials.

Authors:  Elisabeth Eckersberger; Julia Finkelstein; Helen Sadri; Markus Margreiter; Samir S Taneja; Herbert Lepor; Bob Djavan
Journal:  Rev Urol       Date:  2009

2.  Neural protein gamma-synuclein interacting with androgen receptor promotes human prostate cancer progression.

Authors:  Junyi Chen; Li Jiao; Chuanliang Xu; Yongwei Yu; Zhensheng Zhang; Zheng Chang; Zhen Deng; Yinghao Sun
Journal:  BMC Cancer       Date:  2012-12-11       Impact factor: 4.430

3.  Expression of RABEX-5 and its clinical significance in prostate cancer.

Authors:  Hongtuan Zhang; Shang Cheng; Andi Wang; Hui Ma; Bing Yao; Can Qi; Ranlu Liu; Shiyong Qi; Yong Xu
Journal:  J Exp Clin Cancer Res       Date:  2014-04-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.